Effects of Encapsulated Propolis on Blood Glycemic Control, Lipid Metabolism, and Insulin Resistance in Type 2 Diabetes Mellitus Rats

Table 3

Effects of encapsulated propolis on TG in T2DM rats (𝑥  ± S.D.).

Group	Dosage	𝑛	Serum triglycerides (mmol/L)
	(administration)		0 week	2 week	4 week	6 week	8 week	10 week
Normal control	1 mL/100 g; distilled water (p.o.)	12	1.67±0.40	1.89±0.34	1.78±0.38 **	1.80±0.27 **	1.82±0.39 **	2.17±0.37 **
Model control	1 mLl/100 g; distilled water (p.o.)	12	1.56±0.34	1.59±0.34	2.89±0.70	2.98±0.58	3.09±0.54	3.08±0.74
Low-dose EP	50 mg/kg; encapsulated propolis (p.o.)	12	1.60±0.42	1.77±0.55	2.27±0.53 *	2.10±0.38 **	2.15±0.60 **	2.32±0.59
Middle-dose EP	100 mg/kg; encapsulated propolis (p.o.)	12	1.65±0.37	1.79±0.51	2.00±0.26 **	1.78±0.46 **	1.50±0.45 **	1.54±0.59 **
High-dose EP	200 mg/kg; encapsulated propolis (p.o.)	12	1.68±0.44	1.84±0.52	2.43±0.49	2.48±0.47	2.18±0.58 **	2.13±0.65 **
Positive control	10 mg/kg; Pioglitazone HCL (p.o.)	12	1.75±0.55	1.60±0.36	2.13±0.47 **	1.87±0.76 **	1.98±0.69 **	1.59±0.46 **

Tukey post hoc tests: *𝑃<.05 and **𝑃<.01 compared with model control group.